The FDA CHANGED EVERYTHING…
MONDAY MEDICAL BLOG | WOMEN'S HEALTH | HORMONE OPTIMIZATION
Published: March 13, 2026 | Read time: ~8 minutes
The FDA Just Changed Everything About HRT — Here's What Every Woman Needs to Know
For over two decades, millions of women were told that hormone replacement therapy was too dangerous to use. In November 2025, the FDA officially corrected the record — and it changes everything.
If you are a woman in your 40s, 50s, or 60s who has been suffering through menopause symptoms — hot flashes, sleepless nights, brain fog, weight gain, low libido, mood swings, joint pain — and you have been told that hormone replacement therapy is too risky, this article is for you.
In November 2025, the U.S. Food and Drug Administration made a landmark decision: it officially removed the black box warning from hormone replacement therapy products. This is the most significant shift in women's healthcare in over two decades, and most women — and even many providers — don't know it has happened yet.
At Monday Medical, we believe every woman deserves accurate, up-to-date information about her health. So let's break down exactly what changed, what the science actually says, and what it means for you.
What Was the Black Box Warning — And Why Did It Exist?
To understand why this FDA decision matters so much, we need to go back to 2002.
That year, a large government-funded study called the Women's Health Initiative (WHI) released results that sent shockwaves through the medical community. The study suggested that HRT was associated with increased risks of breast cancer, heart disease, stroke, and blood clots. Almost overnight, the FDA added a black box warning — its most serious safety label — to all hormone therapy products.
The fallout was swift and severe. Millions of women stopped their hormone therapy. Prescriptions for HRT dropped by more than 70 percent in the years that followed. Providers became reluctant to prescribe it. Women were told to use the lowest possible dose for the shortest amount of time — or to avoid it entirely.
For over 23 years, that warning shaped how women's hormonal health was treated — or more accurately, how it was not treated.
"For 23 years, women were told to suffer in silence. The FDA has finally acknowledged what the science has been showing for years — HRT is not only safe for most women, it can be profoundly health-protective."
So What Was Wrong With the Original Study?
The short answer: a lot.
Subsequent decades of research have revealed significant problems with the original WHI study that fundamentally undermined its conclusions:
The study used medroxyprogesterone acetate — a synthetic progestogen that is not commonly used in modern hormone therapy and does not behave the same way as bioidentical progesterone.
The average age of women in the study was 63 — well past the optimal window for starting HRT. Starting hormone therapy more than 10 years after menopause carries different risk profiles than starting it during the transition.
The study did not differentiate between types of estrogen, delivery methods, or individual patient profiles.
Follow-up analyses of the same study data showed that younger women who started HRT closer to menopause actually had significantly better outcomes — including reduced cardiovascular risk.
In short, the black box warning was based on flawed data applied to the wrong population using the wrong formulations. Modern hormone therapy is a fundamentally different treatment.
What the FDA Changed — And What It Means
In November 2025, the FDA officially removed the black box warning from hormone replacement therapy products, with the changes taking effect in February 2026.
This is not a minor administrative update. This is the FDA acknowledging that the scientific evidence no longer supports the sweeping risk warnings that have kept women from accessing effective treatment for over two decades.
Here is what specifically changed:
The broad black box warning about cancer, cardiovascular disease, and dementia has been removed from systemic HRT products.
The guidance to use the "lowest effective dose for the shortest possible time" has been lifted — women can now stay on HRT for as long as it is clinically beneficial.
Providers are no longer discouraged from prescribing HRT for menopausal symptom management and prevention.
The FDA's updated guidance recommends starting HRT within 10 years of menopause onset or before age 60 for optimal benefit.
It is important to note that the warning for endometrial cancer risk in women with a uterus taking estrogen alone remains — progesterone is still recommended in these cases. And as with all medical treatments, individual risk factors must be considered. But the blanket prohibition that defined women's healthcare for a generation is gone.
What the New Science Actually Shows
The removal of the black box warning reflects a growing body of evidence that not only clears HRT of the risks it was accused of — but demonstrates that for many women, hormone therapy may be actively health-protective.
50%
Reduced Cardiovascular Risk
Women who start HRT within 10 years of menopause onset show up to 50% reduction in cardiovascular disease risk — the leading cause of death in women over 50.
35%
Lower Alzheimer's Risk
Estrogen plays a critical neuroprotective role. Research shows women who use HRT during the menopausal transition have up to 35% lower risk of developing Alzheimer's disease.
60%
Fewer Bone Fractures
Estrogen is essential for maintaining bone density. Women on HRT experience up to 60% fewer osteoporotic fractures — one of the leading causes of disability and mortality in older women.
An analysis of 30 clinical trials involving over 26,000 women found that HRT was not associated with increased cancer mortality — and that women who began HRT before age 60 actually demonstrated a decreased overall mortality risk compared to women who did not use it.
Read that again: women who start HRT at the right time may live longer, healthier lives than those who do not.
The Symptoms That Have Been Dismissed for Too Long
One of the most damaging consequences of the black box era was not just that women were denied treatment — it was that their symptoms were minimized and dismissed. "It's just menopause" became a reason not to intervene, rather than a reason to provide care.
Hormonal decline during perimenopause and menopause affects virtually every system in the body. The symptoms are real, they are measurable, and they significantly impact quality of life:
Hot flashes and night sweats that disrupt sleep and daily function
Insomnia and disrupted sleep architecture
Brain fog, difficulty concentrating, and memory changes
Unexplained weight gain — particularly around the abdomen
Low libido and changes in sexual function
Mood changes, anxiety, and depression
Fatigue and loss of energy
Joint pain and stiffness
Thinning hair, dry skin, and changes in skin elasticity
Vaginal dryness and urinary symptoms
Loss of motivation and drive
These are not inconveniences to be endured. They are symptoms of a physiological shift that has real consequences for long-term health — and most of them respond well to individualized hormone therapy.
Not All Hormone Therapy Is Created Equal
One of the most important things to understand about modern HRT is that it looks very different from the therapy studied in the original 2002 trial. The evolution of hormone therapy over the past two decades has produced options that are safer, more effective, and more personalized than ever before.
Bioidentical Hormones
Bioidentical hormones are structurally identical to the hormones your body produces naturally. Unlike the synthetic versions used in early studies, bioidentical estrogen and progesterone have different metabolic profiles and — based on current evidence — a more favorable safety profile for most women.
Multiple Delivery Methods
Modern HRT is available in patches, gels, creams, and pellets — not just oral pills. Transdermal delivery in particular bypasses the liver and has been associated with lower risk of blood clots compared to oral estrogen.
Individualized Dosing
One-size-fits-all is not how modern hormone therapy works. Dosing should be based on your specific lab values, symptoms, age, health history, and goals — not a generic protocol.
The Timing Matters
The research is clear that the benefits of HRT are greatest when therapy is initiated within 10 years of menopause onset — ideally during perimenopause or early postmenopause. This is called the "critical window" or "timing hypothesis," and it is one of the strongest findings in modern menopause medicine.
Who Is a Good Candidate for HRT?
While the removal of the black box warning is a significant step forward, hormone therapy is not appropriate for every woman. A thorough evaluation by a knowledgeable provider is essential. HRT is generally considered appropriate for women who:
Are experiencing perimenopausal or menopausal symptoms that affect quality of life
Are within 10 years of their last menstrual period or under age 60
Do not have a personal history of hormone-sensitive breast cancer
Do not have untreated cardiovascular disease or active blood clot disorders
Have had a comprehensive hormone panel and baseline health evaluation
For women with more complex health histories, the decision is more nuanced and requires individualized assessment. At Monday Medical, we take the time to evaluate each patient comprehensively — not just their hormone levels, but their full health picture, risk factors, goals, and preferences.
What This Means If You Have Been Suffering in Silence
If you are one of the millions of women who was told that HRT was dangerous — who has been white-knuckling through menopause without treatment — this FDA decision is for you.
It means your suffering was not inevitable. It means the tools to help you have existed, and the barriers to accessing them were built on flawed science. It means that the standard of care is finally catching up with what many women and their advocates have known for years.
It also means that now — right now — is the best time to have a real conversation with a provider who understands the current evidence, who will take your symptoms seriously, and who will work with you to build a personalized plan.
"You do not have to just push through. You deserve a provider who will actually listen — and a treatment plan built around you."
The Monday Medical Approach to Hormone Optimization
At Monday Medical, hormone optimization has always been one of our core services — because we have always believed that women deserve better than the status quo.
Our approach is different from what most women have experienced in the traditional healthcare system:
We order a comprehensive hormone panel — not just TSH. We look at estradiol, progesterone, testosterone, DHEA-S, SHBG, thyroid function, cortisol, and more.
We take the time to actually understand your symptoms, your history, and your goals — because your lab results are only part of the picture.
We offer multiple HRT options including bioidentical estrogen patches, creams, gels, and pellets, as well as oral and topical progesterone.
We monitor your response to therapy and adjust your protocol based on how you feel and what your follow-up labs show.
We integrate HRT with a comprehensive supplement protocol using professional-grade Thorne supplements to support your hormone therapy and overall health.
We are a Direct Primary Care practice — which means you have a real relationship with your provider, direct access when you need it, and appointments that are not rushed.
We do not just treat your symptoms. We build a plan for the best version of you — at this stage of life and every stage that follows.
Frequently Asked Questions
Is it too late to start HRT if I am already postmenopausal?
The greatest benefits are seen when HRT is started within 10 years of menopause onset or before age 60. That said, HRT may still be appropriate for some women beyond this window — particularly for symptom management and bone health. This is a conversation to have with your provider based on your individual situation.
Will HRT cause weight gain?
This is one of the most common misconceptions about hormone therapy. Properly balanced HRT does not cause weight gain — in fact, hormonal decline during menopause is one of the primary drivers of abdominal weight gain in midlife women. Many women find that hormone optimization actually supports healthier weight management.
Does HRT increase my risk of breast cancer?
This was the central concern driving the original black box warning, and it deserves a careful answer. For most women using bioidentical estrogen plus progesterone, current evidence does not show a meaningful increase in breast cancer risk — and some studies suggest that estrogen alone (in women without a uterus) may actually reduce risk. Women with a personal or strong family history of hormone-sensitive breast cancer require individualized assessment. This is not a blanket yes or no — it is a nuanced conversation that your provider should have with you.
How long does it take to feel the effects of HRT?
Most women begin to notice improvement in symptoms within 4 to 8 weeks of starting therapy, with full effects typically felt at 3 to 6 months. Sleep often improves first, followed by hot flash reduction, energy, and mood. Libido and cognitive improvements can take a bit longer.
Do I need to take HRT forever?
No — but the decision of how long to continue is highly individualized. With the removal of the black box warning, the guidance to use HRT for the "shortest possible time" has been lifted. Some women choose to continue long-term for the cardiovascular, bone, and cognitive benefits. Others use it to navigate the menopausal transition and then taper off. There is no universal answer — your provider should help you make this decision based on your goals and ongoing health assessment.
A Note on Finding the Right Provider
One of the most important takeaways from this FDA change is that not all providers are equally up to date on hormone therapy. Many physicians — particularly those trained during or after the 2002 WHI study — still carry the fear and hesitation that the black box warning instilled. You may encounter providers who are unfamiliar with the FDA update, who continue to discourage HRT, or who are not comfortable prescribing bioidentical options.
You deserve a provider who is current, who takes your symptoms seriously, and who has the time to build a real plan with you. If you have been dismissed or denied treatment, seeking a second opinion is not just reasonable — it is your right.
Ready to Feel Like Yourself Again?
Book your free 15-minute discovery call at mondaymedical.com
Take the Next Step
The FDA has cleared the way. The science is on your side. Now it's your turn.
If you have been living with menopause symptoms and have wondered whether hormone therapy might help you — or if you were told it was too risky and have been suffering unnecessarily — we would love to talk with you.
At Monday Medical, we offer free 15-minute discovery calls so you can ask questions, learn about our approach, and find out whether our hormone optimization program is right for you. No pressure, no obligation — just a real conversation with a provider who cares.
Book your free discovery call today at mondaymedical.com — your best self is waiting.
MEDICAL DISCLAIMER
This blog post is intended for educational purposes only and does not constitute medical advice. The information provided is not a substitute for professional medical evaluation, diagnosis, or treatment. Individual results vary. Always consult with a qualified healthcare provider before starting, stopping, or modifying any medical treatment. Monday Medical currently serves Colorado residents only. Statements made have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
